The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients with metastatic breast cancer enrolled in phase I clinical trials: Clinical outcomes and cohort trends.
 
Jennifer Weiss
No Relationships to Disclose
 
Dexiang Gao
No Relationships to Disclose
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Alexion Pharmaceuticals; Align Oncology; Allergan; Amgen; Biogen; Bristol-Myers Squibb; Celgene; Cigna; Gilead Sciences; Illumina; Lilly; Merck; Pfizer; United Health Group
Consulting or Advisory Role - HSIX
Research Funding - Astellas Pharma (Inst); CytRx Corporation (Inst); Eisai (Inst); Eisai (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Johnson & Johnson (Inst); Medivation (Inst)
 
Virginia F. Borges
Research Funding - Abbott/AbbVie (Inst); Advaxis (Inst); Galena Biopharma (Inst); Incyte (Inst); Merrimack (Inst); Oncothyreon (Inst)
 
Peter Kabos
Consulting or Advisory Role - Lilly
Research Funding - Radius Health (Inst)
 
S. Lindsey Davis
Speakers' Bureau - Teva (I)
Research Funding - Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Merck (Inst); OncoMed (Inst); Roche (Inst); Senhwa Biosciences (Inst)
 
Stephen Leong
Stock and Other Ownership Interests - Antares Pharmaceuticals; Spectrum Pharmaceuticals
Honoraria - Lilly
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst)
 
Jennifer Robinson Diamond
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb